Clinical characteristics, echocardiographic findings, and 6-month outcomes in Ugandan women with peripartum cardiomyopathy
ESC Heart Failure · 2026
DOI: 10.1093/eschf/xvaf005 ↗Kurz gefasst
Fachartikel in der Zeitschrift ESC Heart Failure, 2026. Verfasst von Juliet Nabbaale und 10 weiteren Autor:innen. Beteiligte Einrichtung: Uganda Heart Institute, Upper Mulago Hill, Mulago Hospital Complex, Kampala, Uganda. Hauptthemen laut MEDLINE: Peripartum Cardiomyopathy, Echocardiography, Ventricular Function, Left, Stroke Volume. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Uganda Heart Institute and Cape Heart Institute.
Abstract (Originalsprache)
Introduction
Peripartum cardiomyopathy (PPCM) affects previously healthy women commonly of African ancestry resulting into elevated morbidity and mortality rates. The clinical characteristics of PPCM are diverse but there is yet limited data on outcomes for women with PPCM in Uganda. We sought to elucidate the clinical presentation, echocardiographic findings, and 6-month outcomes among women with PPCM in Uganda.
Methods
A prospective cohort study of 80 PPCM women matched for age were monitored over a 6-month period while on goal-directed medical therapy (GDMT) was conducted. All participants underwent a physical examination, 12-lead electrocardiography, echocardiography and biomarkers including NT-pro BNP and Prolactin at baseline and at 6-month follow-up visit. Additionally, 80 matched controls were recruited at baseline as comparison for the biomarkers.
Results
The mean age of cases and controls was 33.6 ± 6.6 and 30.2 ± 5.9 years respectively. Clinical data for cases were as follows: mean left ventricular ejection fraction (LVEF) was 35.7 ± 11.0%, mean LV global longitudinal strain (GLS) was −11.9 ± 4.7%, mean right ventricular GLS was −14.7 ± 10.9%. A total of 22 (27.5%) participants had a LVEF <35% while 6 (7.5%) participants had severe RV systolic dysfunction. 20 (25%) participants were in NYHA IV. 54 (68%) participants received bromocriptine therapy in addition to other GDMT. Clinical data for controls were as follows: mean LVEF was 67.2 ± 4.5%, mean LV GLS was −17.1 ± 4.9%, all controls had normal RV systolic function parameters. After 6-months of follow-up, 6 (7.5%) of the cases had died. Atrial fibrillation occurred in 2 (2.5%) participants and intracardiac thrombus was documented among 8 (10%) participants. 52 (65%) participants were in NYHA I. LV recovery (LVEF ≥ 50%) was observed in 37 (46.3%) cases.
Conclusion
This study shows a high mortality rate of 7.5% aligning with global studies, the observed high thrombus burden and stroke occurred in 10% and 2.5%, respectively which may indicate severity of LV systolic dysfunction at presentation. Two-thirds of patients received Bromocriptine in addition to GDMT which may explain the high rate of LV recovery in this cohort.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Uganda Heart Institute, Upper Mulago Hill, Mulago Hospital Complex, Kampala, Uganda.
- Division of Cardiology, Department of Medicine, Faculty of Health Sciences, Cape Heart Institute, University of Cape Town, Cape Town, South Africa.
- Department of Obstetrics and Gynaecology, School of Medicine-Makerere University, College of Health Sciences, Kampala, Uganda.
- Department of Chemistry and Biochemistry, Hampton University, Hampton, VA, USA.
- Department of Medicine, School of Medicine-Makerere University, College of Health Sciences, Kampala, Uganda.
ORCID-Profile: Annettee Nakimuli
Förderung
- Uganda Heart Institute and Cape Heart Institute
Zitieren
APA
Nabbaale, J., Sliwa, K., Nakimuli, A., Chakafana, G., Zhang, W., Lwabi, P., Omagino, J., Lubega, S., Sebatta, E., Kayima, J., & Okello, E. (2026). Clinical characteristics, echocardiographic findings, and 6-month outcomes in Ugandan women with peripartum cardiomyopathy. ESC Heart Failure. https://doi.org/10.1093/eschf/xvaf005
Vancouver
Nabbaale J, Sliwa K, Nakimuli A, Chakafana G, Zhang W, Lwabi P, et al. Clinical characteristics, echocardiographic findings, and 6-month outcomes in Ugandan women with peripartum cardiomyopathy. ESC Heart Failure. 2026. doi:10.1093/eschf/xvaf005
BibTeX
@article{Nabbaale2026,
author = {Nabbaale, Juliet and Sliwa, Karen and Nakimuli, Annettee and Chakafana, Graham and Zhang, Wanzhu and Lwabi, Peter and Omagino, John and Lubega, Sulaiman and Sebatta, Elias and Kayima, James and Okello, Emmy},
title = {Clinical characteristics, echocardiographic findings, and 6-month outcomes in Ugandan women with peripartum cardiomyopathy},
journal = {ESC Heart Failure},
year = {2026},
doi = {10.1093/eschf/xvaf005}
}
EUVIMED